TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
CHRS

Coherus BioSciences Inc

Healthcare · Biotechnology

1.30$ -5.1% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Coherus BioSciences Inc (CHRS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 258 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CHRS
Line item 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 27 47 187 212 178 163 99 409 842 679 481 630 449 258
– 25 46 150 158 125 127 72 375 767 602 381 476 342 207
– 15 40 150 158 125 127 72 178 541 417 64 103 126 89
– 15 40 150 158 125 127 72 178 541 417 192 118 126 172
– 0.2 0.4 4.2 1.6 1.9 – -1.7 142 157 123 110 261 122 18
– 10 0.0 -8.2 -4.4 -4.8 0.0 1.7 55 44 38 39 63 70 3.2
– 1.6 1.7 4.5 11 11 13 6.7 16 48 63 85 – – –
– – – 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.0 –
– – – 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 5.0 71 54 46
– 17 90 120 219 159 132 138 304 561 582 618 823 581 197
– 11 54 52 106 56 28 33 115 146 165 139 332 283 142
– 1.7 4.2 11 24 0.9 0.2 – 2.2 3.1 3.5 4.3 2.1 1.7 1.8
– 3.9 3.7 11 29 21 16 15 26 15 16 12 35 28 9.9
– – – 0.0 0.0 100 102 103 178 377 408 226 473 265 37
– 9.2 -42 67 -6.9 19 31 -39 105 281 98 -137 -193 -132 61
– -46 -100 -187 -410 -537 -775 -985 -895 -763 -1,050 -1,342 -1,580 -1,551 -1,383
2.0 2.8 18 8.2 37 42 53 65 73 83 75 78 94 115 120

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?